Acceleration of daily land temperature extremes and correlations with surface energy fluxes

Autor: Chris Huntingford, Peter M. Cox, Paul D. L. Ritchie, Joseph J. Clarke, Isobel M. Parry, Mark S. Williamson

Publikováno v: npj Climate and Atmospheric Science, Vol 7, Iss 1, Pp 1-10 (2024)

Abstract Assessment of climate reanalysis data for land (ECMWF Re-Analysis v5; ERA5-Land) covering the last seven decades reveals regions where extreme daily mean temperatures are rising faster than the average rate of temperature rise of the 6 month

Externí odkaz: https://doaj.org/article/7cdd44bd59384bf0ad2134d72e799293

Emergent constraints for the climate system as effective parameters of bulk differential equations

Autor: Chris Huntingford, Peter M. Cox, Mark S. Williamson, Joseph J. Clarke, Paul D. L. Ritchie

Planning for the impacts of climate change requires accurate projections by Earth system models (ESMs). ESMs, as developed by many research centres, estimate changes to weather and climate as atmospheric greenhouse gases (GHGs) rise, and they inform

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd092712030f3b315b90c6bf600ace9
https://esd.copernicus.org/articles/14/433/2023/

Overshooting tipping point thresholds in a changing climate

Autor: Peter M. Cox, Joseph J. Clarke, Paul Ritchie, Chris Huntingford

Publikováno v: Nature

Palaeorecords suggest that the climate system has tipping points, where small changes in forcing cause substantial and irreversible alteration to Earth system components called tipping elements. As atmospheric greenhouse gas concentrations continue t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d29456bec1bce5512d00a5bc38bae8e8
https://doi.org/10.1038/s41586-021-03263-2

Conditions for the Compost Bomb Instability

Autor: Paul Ritchie, Peter M. Cox, Joseph J. Clarke

Under global warming, soil temperatures are expected to rise. This increases the specific rate of microbial respiration in the soils which in turn warms the soil, creating a positive feedback process. This leads to the possibility of an instability,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::46c9462be8d5e5f6e050e807101bf19e
https://doi.org/10.5194/egusphere-egu2020-9929

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.

Autor: Lippert AH; Department of Chemistry, University of Cambridge, Cambridge, UK., Paluch C; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; MiroBio Ltd, Winchester House, Oxford Science Park, Oxford, UK., Gaglioni M; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Vuong MT; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., McColl J; Department of Chemistry, University of Cambridge, Cambridge, UK., Jenkins E; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Fellermeyer M; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Clarke J; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Sharma S; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Moreira da Silva S; MiroBio Ltd, Winchester House, Oxford Science Park, Oxford, UK., Akkaya B; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Anzilotti C; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Morgan SH; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Jessup CF; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Körbel M; Department of Chemistry, University of Cambridge, Cambridge, UK., Gileadi U; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK., Leitner J; Division of Immune Receptors and T cell Activation, Institute of Immunology, Medical University of Vienna, Vienna, Austria., Knox R; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Chirifu M; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Huo J; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Yu S; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Ashman N; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Lui Y; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Wilkinson I; Absolute Antibody Ltd, Redcar, Cleveland, UK., Attfield KE; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK., Fugger L; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK., Robertson NJ; MiroBio Ltd, Winchester House, Oxford Science Park, Oxford, UK., Lynch CJ; MiroBio Ltd, Winchester House, Oxford Science Park, Oxford, UK., Murray L; MiroBio Ltd, Winchester House, Oxford Science Park, Oxford, UK., Steinberger P; Division of Immune Receptors and T cell Activation, Institute of Immunology, Medical University of Vienna, Vienna, Austria., Santos AM; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Lee SF; Department of Chemistry, University of Cambridge, Cambridge, UK., Cornall RJ; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: richard.cornall@ndm.ox.ac.uk., Klenerman D; Department of Chemistry, University of Cambridge, Cambridge, UK. Electronic address: dk10012@cam.ac.uk., Davis SJ; MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK; Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. Electronic address: simon.davis@imm.ox.ac.uk.

Publikováno v: Immunity [Immunity] 2024 Feb 13; Vol. 57 (2), pp. 256-270.e10.